← Back to all trials
Recruiting
NCT05682612
Prognostic Value of PtcO2 in Patients With COVID-19
Conditions: COVID-19 Acute Respiratory Distress Syndrome
Sex: All
Ages: 18 Years – 80 Years
Enrollment: 40
Sponsor: Southeast University, China
Location: China
Summary
Five percent of patients with COVID-19 progressed to respiratory failure and required ICU admission, such patients often have abnormal oxygen tolerance.
However, there is still a lack of clinical indicators to predict the prognosis and treatment responsiveness of COVID-19.
Eligibility Criteria
Inclusion Criteria:Age: 18-80 years, male or female; Patients with COVID-9 pneumonia (typical imaging features of COVID-19 pneumonia) (oxygen saturation ≤ 93% during air or arterial partial pressure of oxygen (PaO2)/oxygen concentration (FiO2) ≤ 300 mmHg at rest);Exclusion Criteria:Pregnant or lactating women; Patients who refuse to undergo transcutaneous tissue oxygen pressure monitoring; Clinicians believe that patients are not appropriate; Patients undergoing ECMO.
Source: ClinicalTrials.gov (NCT05682612). StuddyBuddy aggregates publicly available trial information.